MWAM
Manhattan West Asset Management’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,712
| Closed | -$1.75M | – | 144 |
|
|
2024
Q2 | $1.75M | Sell |
14,712
-1,160
| -7% | -$138K | 0.47% | 65 |
|
|
2024
Q1 | $1.69M | Buy |
15,872
+1,214
| +8% | +$129K | 0.41% | 66 |
|
|
2023
Q4 | $1.46M | Sell |
14,658
-2,690
| -16% | -$268K | 0.41% | 69 |
|
|
2023
Q3 | $1.36M | Buy |
17,348
+5,373
| +45% | +$423K | 0.42% | 61 |
|
|
2023
Q2 | $1.45M | Buy |
11,975
+6,455
| +117% | +$784K | 0.54% | 56 |
|
|
2023
Q1 | $848K | Buy |
5,520
+320
| +6% | +$49.1K | 0.37% | 73 |
|
|
2022
Q4 | $934K | Buy |
5,200
+152
| +3% | +$27.3K | 0.48% | 65 |
|
|
2022
Q3 | $597K | Buy |
5,048
+493
| +11% | +$58.3K | 0.37% | 71 |
|
|
2022
Q2 | $651K | Buy |
4,555
+737
| +19% | +$105K | 0.39% | 69 |
|
|
2022
Q1 | $658K | Buy |
+3,818
| New | +$658K | 0.36% | 66 |
|